Stay updated on SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Sign up to get notified when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FO-LlGa8KR3ug54YFmnPA0qz6RLc.uncropped.jpg&w=3840&q=75)
Latest updates to the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page
- ChecktodayNo Change Detected
- CheckyesterdayChange DetectedDifference0.1%
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 16 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check18 days agoChange DetectedDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check26 days agoChange DetectedThe value 'Glioblastoma Glioma' has been changed to 'Glioma Glioblastoma'. This represents a reversal in the order of the terms used to describe the condition being studied in the clinical trial.SummaryDifference0.1%
Stay in the know with updates to SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma
Enter your email address, and we'll notify you when there's something new on the SL-701 Vaccine Clinical Trial for Recurrent Glioblastoma page.